LINCOLN CAPITAL CORP - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
LINCOLN CAPITAL CORP ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$55,000
-6.8%
16,172
-23.6%
0.03%
-12.8%
Q4 2020$59,000
+11.3%
21,1620.0%0.04%0.0%
Q3 2020$53,000
-75.6%
21,162
+32.2%
0.04%
-77.1%
Q2 2020$217,000
+20.6%
16,010
-32.6%
0.17%
+109.9%
Q1 2020$180,000
+20.0%
23,7660.0%0.08%
-27.0%
Q4 2019$150,000
+87.5%
23,766
+15.8%
0.11%
+63.2%
Q3 2019$80,000
-18.4%
20,516
+1.2%
0.07%
-20.9%
Q2 2019$98,000
-44.9%
20,273
-6.6%
0.09%
-46.6%
Q1 2019$178,000
+48.3%
21,7080.0%0.16%
+45.0%
Q4 2018$120,00021,7080.11%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders